Video Experimental Relacionado
Updated: May 5, 2026
06:38
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
42.1K
El virus de Epstein-Barr superinduce un nuevo antígeno de diferenciación de células B humanas (B-LAST 1) expresado en
Cell
|September 1, 1982
Resumen
Los investigadores identificaron un nuevo antígeno de células B, B-LAST 1, en las células B transformadas y cancerosas. Este descubrimiento ofrece potencial para atacar las células B malignas y las células infectadas por virus.
Área de la Ciencia:
- Inmunología Inmunología.
- Biología celular Biología celular.
- Oncología Oncología.
Sus antecedentes:
- Los antígenos de diferenciación de células B son cruciales para comprender el desarrollo y la transformación de las células B.
- La identificación de marcadores específicos en las células B transformadas puede ayudar en el diagnóstico y las terapias dirigidas.
Objetivo del estudio:
- Desarrollar un anticuerpo monoclonal para detectar un nuevo antígeno de diferenciación específico de células B humanas.
- Para caracterizar el patrón de expresión y la importancia potencial de este antígeno en la transformación de células B.
Principales métodos:
- Desarrollo de un anticuerpo monoclonal.
- Análisis inmunohistoquímico de varios tipos de células, incluidas las células B normales y neoplásicas, las células T y las células mieloides.
- Caracterización de la expresión de antígenos en células transformadas in vitro e in vivo.
Principales resultados:
- Se generó un anticuerpo monoclonal, identificando un nuevo antígeno denominado B-LAST 1.
- B-LAST 1 se expresa específicamente en los linfoblastos de células B transformados por el virus de Epstein-Barr (EBV) y el mitógeno de pokeweed, así como en las células B neoplásicas (leucemia linfocítica crónica, linfoma).
- El antígeno (45.000 MW) estaba ausente en las células T, nulas y mieloides, pero estaba altamente expresado en las células infectadas por el EBV, lo que sugiere un papel en la transformación.
Conclusiones:
- B-LAST 1 es un nuevo antígeno específico de células B asociado con la transformación de células B.
- Su patrón de expresión restringida sugiere potencial como un marcador de diagnóstico y un objetivo para la inmunoterapia contra tumores malignos de células B y células infectadas por el EBV.
Videos de Conceptos Relacionados
01:31Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
01:20Special Features of Adaptive Immunity
3.7K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.7K
01:23Cells of the Adaptive Immune Response
6.9K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
6.9K
01:28Diversity of Antigen Receptors
2.2K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
2.2K
01:24B Cell Activation and Differentiation
14.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
14.5K